Company Filing History:
1 out of 541 
1 out of 1 Years Active: 2007
Title: The Innovative Contributions of Gregory Prince
Introduction
Gregory Prince, an accomplished inventor based in Potomac, MD, has made significant strides in the field of medical innovations. With expertise in respiratory diseases, he has developed groundbreaking therapies aimed at improving patient outcomes. His work exemplifies the intersection of scientific research and therapeutic application, showcasing the impact of innovation on healthcare.
Latest Patents
His notable patent, titled "Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents," presents therapeutically effective anti-viral compositions. These are especially useful against respiratory diseases caused or mediated by the respiratory syncytial virus (RSV). The patent details compositions that include at least one anti-RSV antibody, particularly high-affinity antibodies, alongside additional anti-inflammatory agents, such as corticosteroids and anti-inflammatory antibodies like anti-interleukin-6. The invention also includes methodologies for using these compositions to therapeutically treat and potentially prevent respiratory diseases.
Career Highlights
Throughout his career, Gregory Prince has made substantial contributions to prominent organizations. He has notably worked at MedImmune Limited and Virion Systems, Inc., where he leveraged his skills in developing innovative therapeutic solutions. His experiences at these companies have enriched his understanding of both research and application in the pharmaceutical industry.
Collaborations
Collaboration has played an essential role in Gregory's work, particularly with his colleague, Leslie Sydnor Johnson. Together, they have contributed to the advancement of respiratory disease treatments, demonstrating the value of teamwork in scientific discovery.
Conclusion
Gregory Prince's contributions to medical therapy underscore the importance of innovation in treating respiratory diseases. His patent serves as a testament to the potential of combining antibody therapies with anti-inflammatory agents, highlighting the transformative power of research and collaboration in healthcare. As he continues to develop new solutions, the impact of his work will undoubtedly leave a lasting legacy in the medical field.